glp 1 and prostate cancer Glucagon-like peptide receptor agonists risk: advancing precision medicine through mechanistic understanding and clinical evidence | Biomarker Research GLP1 Receptor Agonism Alters Growth

Diabetologia (2013) 56:14136

Compounding and Sourcing A major driver of the microdosing trend is the use of compounded semaglutide (the active ingredient in Ozempic and Wegovy)

Redel-Macas, C

Dietitians play a critical role in: Adjusting meal timing and composition Managing fat and fiber intake appropriately Identifying trigger foods Supporting hydration strategies The result

For instance, in September 2025, the World Health Organization (WHO) updated its Model Lists of Essential Medicines (EML)

Very interesting paper on an important topic SGLT2is, GLP-1RAs and nsMRAs has significantly transformed clinical guidelines in recent decades shiowing numerous positive including CV and nephroprotection In type 2 diabetes, early evidence suggests that integrating these treatments may offer superior survival and cardiovascular outcomes compared to using single agents